Jeena Sikho Lifecare appoints new Company Secretary and five directors after board resignations

What Jeena Sikho Lifecare announced

On 15 July 2026, Jeena Sikho Lifecare Ltd (BSE: 544476) held a board meeting that resulted in several key managerial changes. The board accepted the resignation of Mrs. Smita Chaturvedi from the roles of Company Secretary, Compliance Officer and Key Managerial Personnel. In her place, Ms. Priya Goyal was appointed to the same positions. Additionally, the board proposed the appointment of four new directors, each falling under distinct categories defined by the Companies Act, 2013.

"The board resolved to appoint Ms. Priya Goyal as Company Secretary and Compliance Officer, and to nominate four additional directors, subject to shareholder approval." (Board resolution, 15 July 2026)

Resignations and new appointments

• Resignation: Mrs. Smita Chaturvedi stepped down from her responsibilities as Company Secretary, Compliance Officer and Key Managerial Personnel. The filing does not disclose any compensation or notice period details.
• New Company Secretary: Ms. Priya Goyal was appointed to succeed Mrs. Chaturvedi. The appointment is effective immediately and will continue until the next annual general meeting or until a successor is appointed.
• Additional Directors:
  1. Mr. Ajay Sharma (DIN: 07671350) – appointed as an Additional Director in the Non‑Executive Independent category.
  2. Mrs. Sapna Singh (DIN: 11812894) – appointed as an Additional Director in the Non‑Executive Women Independent category.
  3. Dr. Ish Sharma (DIN: 11815526) – appointed as an Additional Director in the Executive category and designated as a Whole‑Time Director.
  4. Mr. Ankush Kaushal (DIN: 03308862) – appointed as an Additional Director in the Executive category and designated as a Whole‑Time Director.

All four director appointments are conditional upon approval by the shareholders at the forthcoming general meeting, as required by Section 149 of the Companies Act.

Director categories and regulatory approvals

The board’s decision reflects a balanced mix of independent and executive oversight:

• Independent directors (Mr. Ajay Sharma and Mrs. Sapna Singh) enhance board independence and comply with SEBI’s listing requirements for gender diversity and independence.
• Executive directors (Dr. Ish Sharma and Mr. Ankush Kaushal) will be involved in day‑to‑day management and are expected to hold a minimum shareholding as stipulated by law. The appointments will be filed with the Registrar of Companies (RoC) and disclosed in the next statutory filing.

Key facts at a glance

Why this matters for investors

The change in Company Secretary may affect the company’s compliance pipeline, as the new officer will oversee statutory filings, board minutes, and regulatory disclosures. Adding independent directors aligns the board with corporate‑governance best practices, potentially improving oversight and risk management. Executive directors who are also Whole‑Time Directors will have direct influence on operational decisions, which could impact execution of the company’s strategic plans. Until shareholder approval is obtained, the appointments remain provisional, and the company must continue to disclose any further changes.

Conclusion

Jeena Sikho Lifecare’s board has acted to fill a key secretarial vacancy and to broaden its board with a mix of independent and executive directors. All appointments are pending ratification at the next general meeting, after which the company will update its statutory registers and inform the market of the finalized board composition.